Pharmacopeia
	Developer of novel small molecule therapeutics to address significant medical needs. The company has a portfolio of clinical and preclinical candidates under development internally or with partners including nine clinical compounds in Phase 2 or Phase 1 development addressing hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease.
	['', 'small molecule', ' hypertension ', 'diabetic nephropathy', '']
Argintex
	Developer of therapeutics like small molecule inhibitors of arginase.The companyâ€™s arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis.
	['', 'molecule inhibitor', ' ', 'pulmonary treatment', ' ', 'vascular disorder', ' ', 'arginase enzyme', '']
Diaxonhit
	Developer of RNA-based diagnostic tests. The company is engaged in developing RNA-based diagnostic tests and small molecule therapeutics for the treatment of Alzheimer\'s disease (AD) and cancer. Its Genome Wide SpliceArray (GWSA) platform is a patented microarray design that incorporates a specific probe configuration, enabling monitoring of RNA splice variants in humans, mice and rats.
	['', 'diagnostic test', ' ', 'small molecule', ' ', 'RNA splice', '']
Xanthus Pharmaceuticals
	Developer of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
	['', 'cancer treatment', ' ', 'small-molecule therapeutic', ' ', 'autoimmune disorder', '']
HemaQuest Pharmaceuticals
	Developer of small molecule therapeutics. The company develops small molecule therapeutics based on its short chain fatty acid derivative (SCFAD) technologies to treat anemia and other blood disorders.
	['', 'blood disorder treatment', ' ', 'anemia treatment', ' ', 'small molecule therapeutic', '']
Galileo Pharmaceuticals
	Developer of small molecule therapeutics. The company specializes in the discovery of compounds that moderate the effects of oxidative stress and energetic perturbations on living biological systems.
	['', 'small molecule therapeutics', ' ', 'metabolic diseases', ' oxidative ', 'metabolic stress', '']
Gloucester Pharmaceuticals
	Developer of cancer therapeutics. The company develops romidepsin, a histone deacetylase inhibitor and oncology drug candidate for T-cell lymphomas, as well as for the treatment of hematologic malignancies. It also develops treatments for hematological cancers, including cutaneous T-cell lymphoma, peripheral T-cell lymphoma, and multiple myeloma.
	['', 'cancer therapy', ' ', 'hematological cancer treatment', ' ', 'cancer drug', '']
Ardea Biosciences
	Developer of small-molecule therapeutics. The company provides therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV)..
	['', 'small molecule therapeutic', ' ', 'disease treatment', ' ', 'gout treatment', ' ', 'cancer drug', ' ', 'cancer treatment', ' ', 'HIV drug', ' ', 'HIV treatment', '']
Signase
	Developer of small molecule inhibitors of a critical cell pathway for the treatment of a variety of solid tumors.
	['', 'molecule inhibitor', ' ', 'solid tumor treatment', ' ', 'critical cell pathway', '']
Pathway Therapeutics
	Developer of therapeutics against human diseases. The company offers PI3 kinase, an enzyme identified as active in cancer tumor development.
	['', 'drug development', ' ', 'cancer treatment', ' ', 'lifesciences and oncology', '']
Tobira Therapeutics (acquired 2015)
	Developer of antiviral compounds for treating HIV infection. The company develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis and other associated infectious conditions.
	['', 'antiviral compound', ' ', 'HIV treatment', ' ', 'hepatitis treatment', '']
ViroChem Pharma
	Developer and producer of the drugs and pharmaceutical products for viral disease. The company manufacture, develop and produce the medicine products for viral infection, Hepatitis C (HCV) and human immunodeficiency virus (HIV).
	['', 'pharmaceutical product', ' ', 'drug research', ' ', 'human immunodeficiency virus', '']
Conatus Pharmaceuticals
	Provider of human therapeutics to treat liver diseases. The company offers CTS-1027, an oral, small molecule and matrix metalloproteinase inhibitor for the treatment of liver disease.
	['', 'human therapeutic', ' ', 'liver disease', ' ', 'drug discoverer', '']
Stemline Therapeutics
	Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.
	['', 'oncology', ' ', 'cancer stem cell', ' ', 'interleukin receptor', ' ', 'hematological cancer', ' ', 'leukemia blast', '']
Tacere Therapeutics
	Developer of therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company utilizes gene silencing technology called DNA-directed RNA interference (ddRNAi).
	['', 'Hepatitis C', ' ', 'RNAi therapeutic', ' ', 'RNA interference drug', '']
Artesian Therapeutics
	Developer of small molecule therapeutics for the treatment of cardiovascular diseases. The company provides small molecule drugs for congestive heart failure.
	['', 'cardiovascular disease treatment', ' ', 'small molecule therapeutic', ' ', 'congestive heart failure', '']
Adamas Pharmaceuticals
	Developer of small molecule advantaged therapeutics to treat neurological and infectious diseases. The company also develops novel extended release and combination products for symptomatic treatment of dementia.
	['', 'small molecule', ' ', 'advantaged therapeutic', ' ', 'neurological disease', ' ', 'symptomatic treatment', ' dementia']
